CDKN2A and Miyoshi myopathy: In multiple myeloma (MM), a cancer affecting plasma cells, several tumor suppressor genes (e.g., CDKN2A, CDKN2B, SOCS1, and SHP1) are hypermethylated in the CpG islands of their promoters, leading to gene translation inhibition [37].